IDEAL_ANSWER:
- Dasatinib and Blinatumomab produces molecular responses in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

EXACT_ANSWER:
- Philadelphia chromosome-positive acute lymphoblastic leukemia